84 studies found for:
"Beta-thalassemia"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Unknown † |
Beta-thalassemia and Microparticles
|
||||
| 2 | Completed |
Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia
|
||||
| 3 | Completed |
Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment
|
||||
| 4 | Completed |
A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis
|
||||
| 5 | Completed |
Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)
|
||||
| 6 | Recruiting |
Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major
|
||||
| 7 | Completed |
Efficacy Study of the Use of Sequential DFP-DFO Versus DFP
|
||||
| 8 |
Completed
Has Results |
Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)
|
||||
| 9 | Completed |
Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload
|
||||
| 10 | Completed |
Evaluating the Safety of G-CSF Mobilization in Individuals With Beta Thalassemia Major
|
||||
| 11 | Not yet recruiting |
A Study Evaluating the Safety and Efficacy of the LentiGlobin® BB305 Drug Product in Beta-Thalassemia Major Subjects
|
||||
| 12 | Completed |
Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions
|
||||
| 13 | Unknown † |
Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major
|
||||
| 14 | Recruiting |
Study of ACE-536 to Evaluate the Effects of ACE-536 in Patients With Beta-thalassemia Intermedia
|
||||
| 15 | Completed |
Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI
|
||||
| 16 | Completed |
Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia
|
||||
| 17 | Completed |
Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias
|
||||
| 18 | Completed |
Trial of HQK-1001 in Beta Thalassemia Intermedia in Lebanon
|
||||
| 19 | Unknown † |
Genetic Factors Affecting the Severity of Beta Thalassemia
|
||||
| 20 | Active, not recruiting |
Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients
|
† Indicates status has not been verified in more than two years
